149 related articles for article (PubMed ID: 9688338)
1. Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice.
Erälinna JP; Röyttä M; Hukkanen V; Zinhu D; Salmi AA; Salonen R
J Neuroimmunol; 1998 Aug; 88(1-2):165-76. PubMed ID: 9688338
[TBL] [Abstract][Full Text] [Related]
2. Semliki Forest virus infection is enhanced in Th1-prone SJL mice but not in Th2-prone BALB/c mice during Linomide-induced immunomodulation.
Peltoniemi J; Setälä N; Broberg E; Röyttä M; Hukkanen V; Salmi AA; Erälinna JP
J Neuroimmunol; 2002 Nov; 132(1-2):83-92. PubMed ID: 12417437
[TBL] [Abstract][Full Text] [Related]
3. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
Karussis D; Abramsky O; Rosenthal Y; Mizrachi-Koll R; Ovadia H
Immunol Lett; 1999 Apr; 67(3):203-8. PubMed ID: 10369127
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
Lehmann D; Karussis DM; Fluresco D; Mizrachi-Koll R; Ovadia H; Shezen E; Kalland T; Abramsky O
J Neuroimmunol; 1997 Apr; 74(1-2):102-10. PubMed ID: 9119961
[TBL] [Abstract][Full Text] [Related]
5. Immune responses, and autoimmune outcome, during virus infection of the central nervous system.
Mokhtarian F; Shi Y; Zhu PF; Grob D
Cell Immunol; 1994 Aug; 157(1):195-210. PubMed ID: 7518751
[TBL] [Abstract][Full Text] [Related]
6. The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells.
Rowell JF; Griffin DE
J Immunol; 1999 Feb; 162(3):1624-32. PubMed ID: 9973422
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes.
Weiss L; Barak V; Zeira M; Abdul-Hai A; Raibstein I; Reich S; Hirschfeld E; Gross D; Slavin S
Cytokine; 2002 Jul; 19(2):85-93. PubMed ID: 12182843
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis.
Erälinna JP; Soilu-Hänninen M; Röyttä M; Hukkanen V; Salmi AA; Salonen R
J Neuroimmunol; 1996 May; 66(1-2):103-14. PubMed ID: 8964903
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
Donnelly SM; Sheahan BJ; Atkins GJ
Neuropathol Appl Neurobiol; 1997 Jun; 23(3):235-41. PubMed ID: 9223133
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
Peltoniemi J; Broberg EK; Nygårdas M; Erälinna JP; Waris M; Hukkanen V
Int Immunopharmacol; 2006 May; 6(5):817-29. PubMed ID: 16546713
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of experimental allergic encephalomyelitis by irradiation and virus infection: role of inflammatory cells.
Erälinna JP; Soilu-Hänninen M; Röyttä M; Ilonen J; Mäkelä A; Salonen R
J Neuroimmunol; 1994 Nov; 55(1):81-90. PubMed ID: 7962484
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection.
Morris MM; Dyson H; Baker D; Harbige LS; Fazakerley JK; Amor S
J Neuroimmunol; 1997 Apr; 74(1-2):185-97. PubMed ID: 9119972
[TBL] [Abstract][Full Text] [Related]
13. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
[TBL] [Abstract][Full Text] [Related]
14. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis.
Falcone M; Bloom BR
J Exp Med; 1997 Mar; 185(5):901-7. PubMed ID: 9120396
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
[TBL] [Abstract][Full Text] [Related]
16. Herbal medicine Gamgungtang down-regulates autoimmunity through induction of TH2 cytokine production by lymphocytes in experimental thyroiditis model.
Sa EH; Jin UH; Kim DS; Kang BS; Ha KT; Kim JK; Park WH; Kim CH
J Ethnopharmacol; 2007 Feb; 109(3):472-9. PubMed ID: 17049774
[TBL] [Abstract][Full Text] [Related]
17. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
Smyth JM; Sheahan BJ; Atkins GJ
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
19. Linomide, an immunomodulator that inhibits Th1 cytokine gene expression.
Arad G; Katzenellenbogen M; Levy R; Slavin S; Kaempfer R
Int Immunol; 1996 Oct; 8(10):1603-7. PubMed ID: 8921440
[TBL] [Abstract][Full Text] [Related]
20. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males.
Matarese G; Sanna V; Di Giacomo A; Lord GM; Howard JK; Bloom SR; Lechler RI; Fontana S; Zappacosta S
Eur J Immunol; 2001 May; 31(5):1324-32. PubMed ID: 11465089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
